Every 8-K that RF Acquisition Corp II (RFAI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow RFAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RFAI filings page.
RF Acquisition Corp II (RFAI) reported results of an extraordinary general meeting held on August 19, 2026 to vote on its proposed business combination with Nanyang Biologics Pte. Ltd. through NYB Holdings Limited (PubCo). Shareholders approved the Business Combination Agreement, the merger of RF Acquisition Corp II into PubCo, the related Nasdaq share issuance, governance provisions, and the NYB Holdings Limited Equity Incentive Plan. An adjournment proposal was also approved but was not needed.
Out of 8,343,765 ordinary shares entitled to vote as of May 20, 2026, 7,206,188 shares (approximately 86.36%) were represented, and each proposal received 6,765,584 votes for and 440,604 against. Holders submitted preliminary requests to redeem 3,956,323 ordinary shares from the Trust Account; these requests may change, and the business combination closing remains subject to satisfaction or waiver of closing conditions.
RF Acquisition Corp II obtained shareholder approval on August 12, 2026 to extend the deadline to complete a business combination beyond August 15, 2026, allowing up to six one‑month extensions through February 15, 2027. Each monthly extension requires depositing $75,000 into the Trust Account in exchange for a non‑interest bearing, unsecured promissory note payable upon a business combination.
The Investment Management Trust Agreement was amended to implement these extensions and to eliminate the company’s prior right to withdraw up to $100,000 of trust interest for liquidation and dissolution expenses. Shareholders also approved corresponding amendments to the company’s charter.
In connection with the meeting, holders of 833,157 ordinary shares redeemed their shares for approximately $9,277,866.57 (about $11.13 per share). After these redemptions, approximately $44,522,115.92 remains in the Trust Account and the company has 3,998,108 ordinary shares outstanding.
RF Acquisition Corp II reported shareholder approval to amend its charter and trust agreement, permitting up to nine one‑month extensions to complete a business combination through August 15, 2026. Each monthly extension requires a deposit of $0.03 per public share not redeemed, up to $60,000 per month, after five days’ advance notice to the trustee.
At the November 10 meeting, proposals passed with 9,600,561 votes for and 3,280,531 against. In connection with the vote, holders redeemed 6,668,735 ordinary shares for approximately $10.73 per share, removing about $71,580,705 from the trust. Following redemptions, approximately $51,857,714 remains in the trust. Shares outstanding are 8,343,765, including 4,831,265 public shares.
RF Acquisition Corp II signed a Business Combination Agreement to combine with Nanyang Biologics Pte. Ltd. through a new Cayman holding company, NYB Holdings Limited (PubCo). RF Acquisition Corp II will merge into PubCo, and Nanyang will amalgamate with a PubCo subsidiary, leaving Nanyang as a wholly owned PubCo subsidiary.
Each RF Acquisition Corp II ordinary share will be exchanged for one PubCo ordinary share, and each outstanding right will convert into one‑twentieth of a PubCo share. Nanyang shareholders will receive newly issued PubCo shares based on agreed formulas in the merger contract.
Closing depends on effectiveness of a Form F‑4 registration statement, shareholder approvals at RF Acquisition Corp II and Nanyang, PubCo’s listing approval on Nasdaq or NYSE, accuracy of representations, covenant compliance, and absence of legal blocks. Support and lock‑up agreements commit Nanyang holders of at least 75% of voting shares and the RF Acquisition Corp II founder to vote for the deal and restrict sales of their PubCo shares for up to 24 months after closing.